Related Articles
Role and mechanisms of action of microRNA‑21 as regards the regulation of the WNT/β‑catenin signaling pathway in the pathogenesis of non‑alcoholic fatty liver disease
Treatment of experimental non‑alcoholic steatohepatitis by targeting α7 nicotinic acetylcholine receptor‑mediated inflammatory responses in mice
Non‑alcoholic fatty liver disease: A major challenge in type 2 diabetes mellitus (Review)
Efficacy of orlistat in non‑alcoholic fatty liver disease: A systematic review and meta‑analysis
A3 adenosine receptor agonist, CF102, protects against hepatic ischemia/reperfusion injury following partial hepatectomy